Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C

Published:2013-07 Issue:1-2 Volume:154 Page:61-69
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Araújo Ana Ruth,Peruhype-Magalhães Vanessa,Coelho-dos-Reis Jordana Grazziela Alves,Chaves Laura Patrícia Viana,Lima Tatiane Amábili de,Pimentel João Paulo Diniz,de Paula Lúcia,Almeida Carlos Maurício de,Tarragô Andréa Monteiro,Tateno Adriana,Levi José Eduardo,Teixeira-Carvalho Andrea,Martins-Filho Olindo de Assis,Lira Edson da Fonseca,Torres Kátia Luz,Talhari Sinésio,Malheiro Adriana

Funder

Fundação de Amparo à Pesquisa do Estado do Amazonas

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Hanafiah;Hepatology,2013